Safety tracking study for Awiqli in diabetes
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study monitors how well Awiqli works and any side effects in people with diabetes. It's designed to gather real-world safety information, so you can take Awiqli as your doctor prescribes while contributing to important research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been prescribed Awiqli by your doctor for your diabetes.
- You have any type of diabetes (type 1, type 2, etc.).
- You are any age and either male or female.
- You can understand and agree to take part in the study.
- You haven’t had low blood sugar symptoms or an allergic reaction to Awiqli ingredients.
- You are not currently in another drug study or had an experimental drug in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This trial tests a new medicine, LY4057996, in people with type 1 or type 2 diabetes and in healthy volunteers. It aims to see if the drug is safe and how it works in the body.
This Phase 3 study tests whether LID104 can improve blood sugar control and safety in people with type 2 diabetes who are not meeting their A1c goal on metformin. You may benefit if your diabetes is still too high despite diet, exercise, and the usual metformin dose.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study tests an upgraded automated insulin pump system that uses artificial intelligence to better predict and prevent blood sugar swings. If you have Type 1 Diabetes and already use an automated insulin pump, this trial may help you achieve better blood sugar control.
This study tests whether an AI-powered system can help doctors who are not diabetes specialists improve blood sugar control in people with type 2 diabetes. You may be eligible if your blood sugar is not well controlled despite taking diabetes pills.
Hear when a new Diabetes Mellitus, Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.